Nobel laureate behind Bristol's I-O superstar Opdivo demands a bigger cut

Opdivo, the blockbuster cancer drug co-developed by Japan’s Ono Pharmaceutical and sold in the U.S. by Bristol-Myers Squibb, is a cash cow in the global market. But a Nobel laureate who helped create the drug isn’t happy with his share.